文献速递甲状腺疾病垂体与肾上腺疾病

长期多发性内分泌腺瘤病2型患者的抑郁、焦虑、生活质量与应对方式评估

Assessment of Depression, Anxiety, Quality of Life, and Coping in Long-Standing Multiple Endocrine Neoplasia Type 2 Patients.
PubMed 文献 · Thyroid · 2017-04-04

该横断面研究纳入43例长期随访(10.6±8.2年)的多发性内分泌腺瘤病2型(MEN2)成人患者,采用半定向访谈及HADS、EORTC QLQ C30、MINI-MAC量表评估心理状况。焦虑症状占42%,抑郁症状占26%,心理困扰可能呈慢性化。疾病信息充分、治愈状态等因素与心理量表结果相关。

要点

  • MEN2长期患者焦虑症状常见(42%),抑郁症状占26%。
  • 向子女传递RET突变者内疚感占35%,且弱化-沮丧/焦虑专注评分更高。
  • 疾病信息充分的33例患者抑郁和焦虑评分更低,角色、认知和情绪功能评分更高。

核心结论

  • MEN2患者的心理困扰可能呈慢性化。
  • 研究识别出疾病信息程度、突变阳性子女、手术次数、合并症、应激因素和治愈状态等MEN2相关因素对心理测量量表结果产生正面或负面影响。
  • 主动调查这些因素并应用心理评估方案有助于识别需要心理援助的MEN2患者。

研究设计与样本

  • 横断面研究,纳入43例临床和基因诊断的MEN2成人患者(年龄≥18岁),长期随访10.6±8.2年(范围1-33年)。
  • 采用半定向访谈及HADS、EORTC QLQ C30和MINI-MAC量表进行定性和定量心理评估。
  • 采用2015年ATA MEN2指南临床标准评估甲状腺髓样癌(MTC)状态:生化治愈39%(16/41),持续/复发61%(25/41),稳定慢性疾病22/41。
  • 嗜铬细胞瘤累及19例(44%),其中17例曾行肾上腺切除术。

主要发现

  • 总体焦虑症状占42%(平均分11±2.9,范围8-18;焦虑定义为评分≥8),抑郁症状占26%(平均分11±3.8,范围8-20;抑郁定义为评分≥8)。
  • 向子女传递RET突变的患者弱化-沮丧/焦虑专注评分更高,认知、情绪和躯体功能评分更低(p < 0.05);突变阳性子女的患者中内疚感占35%。
  • 疾病信息充分的33例患者抑郁和焦虑平均评分更低,角色、认知和情绪功能评分更高(p < 0.05)。
  • 多次手术患者(p = 0.019)和慢性肾上腺功能不全控制者(p = 0.024)更常见战斗精神。
  • 有MEN2相关应激因素的患者战斗精神和认知功能评分更低,失眠和呼吸困难评分更高(p < 0.05);11例需要持续心理治疗;平均总体健康状况较好(68.1±22.3),治愈组躯体功能更高(p = 0.021)。

关键数值与推荐

  • 焦虑定义为HADS评分≥8,抑郁定义为HADS评分≥8。
  • 生化治愈39%(16/41),持续/复发61%(25/41),稳定慢性疾病22/41。
  • 嗜铬细胞瘤19例(44%),肾上腺切除术17例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data on psychological harm in multiple endocrine neoplasia type 2 (MEN2) are scarce. OBJECTIVES: The aim of this study was to assess anxiety, depression, quality of life, and coping in long-standing MEN2 patients. PATIENTS AND METHODS: Patients were 43 adults (age ≥18 years) with clinical and genetic diagnosis of MEN2 and long-term follow-up (10.6 ± 8.2 years; range 1-33 years). This was a cross-sectional study with qualitative and quantitative psychological assessment using semi-directed interviews and HADS, EORTC QLQ C30, and MINI-MAC scales. Adopting clinical criteria from 2015 ATA Guidelines on MEN2, biochemical cure (39%; 16/41), persistence/recurrence (61%; 25/41), and stable chronic disease (22/41) of medullary thyroid carcinoma (MTC) were scored. Pheochromocytoma affected 19 (44%) patients, with previous adrenalectomy in 17 of them. RESULTS: Overall, anxiety (42%; mean score 11 ± 2.9; range 8-18; anxiety is defined as a score ≥8) and depression (26%; mean score 11 ± 3.8; range 8-20; depression is defined as a score ≥8) symptoms were frequent. Patients who transmitted RET mutations to a child had higher scores for weakness-discouragement/anxious preoccupation and lower scores for cognitive, emotional, and physical functioning (p < 0.05). Feelings of guilt were present in 35% of patients with mutation-positive children. Lower mean score values for depression and anxiety and higher scores for role, cognitive, and emotional functioning were noticed in 33 patients who were well-informed about their disease (p < 0.05). Fighting spirit was more frequently found in patients with multiple surgical procedures (p = 0.019) and controlled chronic adrenal insufficiency (p = 0.024). Patients with MEN2-related stress-inducing factors had lower scores for fighting spirit and cognitive functioning and higher scores for insomnia and dyspnea (p < 0.05). Eleven patients required sustained psychotherapeutic treatment. Mean global health status was relatively good in MEN2 cases (68.1 ± 22.3), and the cured group had higher physical functioning (p = 0.021). CONCLUSIONS: Psychological distress is likely chronic in MEN2 patients. This study identified diverse MEN2-related factors (degree of information on disease, mutation-positive children, number of surgeries, comorbidities, stress-inducing factors, and cure) interfering positively or negatively with the results of the psychometrics scales. The active investigation of these factors and the applied psychological assessment protocol are useful to identify MEN2 patients requiring psychological assistance.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Rodrigues KC, Toledo RA, Coutinho FL, et al. Assessment of Depression, Anxiety, Quality of Life, and Coping in Long-Standing Multiple Endocrine Neoplasia Type 2 Patients. Thyroid. 2017. PMID: 28276947. doi:10.1089/thy.2016.0148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。